Wordt geladen...
Targeting the ubiquitin-mediated proteasome degradation of p53 for cancer therapy
Within the past decade, there has been a revolution in the types of drugs developed to treat cancer. Therapies that selectively target cancer-specific aberrations, such as kinase inhibitors, have made a dramatic impact on a subset of patients. In spite of these successes, there is still a dearth of...
Bewaard in:
| Hoofdauteurs: | , |
|---|---|
| Formaat: | Artigo |
| Taal: | Inglês |
| Gepubliceerd in: |
2013
|
| Onderwerpen: | |
| Online toegang: | https://ncbi.nlm.nih.gov/pmc/articles/PMC3637405/ https://ncbi.nlm.nih.gov/pubmed/23151129 |
| Tags: |
Voeg label toe
Geen labels, Wees de eerste die dit record labelt!
|